1-(4-(Pyrrolidin-1-yl)phenyl)ethan-1-amine, 95%, 250mg

5-Hydroxymethylfurfural, min. 97%, for synthesis, 5 g, glass packaging

Dehydronitrosonisoldipine, 10mg

3-Fluoro-2-nitrophenol>98.0%(GC)(T)1g

Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate, 95.0%, 250mg

2-Chloro-4-fluoroaniline, 99.0%, 1g

Ethyl 2-methylquinoline-6-carboxylate, 95.0%, 250mg

Ethyl-2,2-difluoro-2-(3,4-difluorophenyl)acetate, 95.0%, 1g

3,3'-(5'-(3-(Pyridin-3-yl)phenyl)-[1,1':3',1''-terphenyl]-3,3''-diyl)dipyridine, 97%, 100mg

3-((tert-Butoxycarbonyl)amino)azetidine-3-carboxylic acid, 95%, 100mg

1'-(tert-Butoxycarbonyl)-1,4'-bipiperidine-4-carboxylic acid, 97.0%, 5g

(5R)-2,2-DIOXIDO-5-METHYL-1,2,3-OXATHIAZOLIDINE, N-BOC PROTECTED, 95.0%, 1g

tert-Butyl (3-mercaptophenyl)carbamate, 98%, 250mg